(Q33657377)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

J Cortes

12

1 reference

ORCID Public Data File 2021

author name string

H Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C Bueso-Ramos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C DiNardo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Davanlou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Q-R Geng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Z Fang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Nguyen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Pierce

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Y Wei

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Parmar

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

H Kantarjian

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

G Garcia-Manero

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

25 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

1280-1288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2013.355

1 March 2020

exact match

0 references

cites work

Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Molecular action of lenalidomide in lymphocytes and hematologic malignancies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Immune dysregulation in myelodysplastic syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Failure of hypomethylating agent-based therapy in myelodysplastic syndromes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Clinical effect of point mutations in myelodysplastic syndromes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Myelodysplastic syndromes: the role of the immune system in pathogenesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Targeting immune dysregulation in myelodysplastic syndromes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Interferon-α in acute myeloid leukemia: an old drug revisited

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Myeloid-derived suppressor cells as regulators of the immune system

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Clinical significance of regulatory T cells in patients with myelodysplastic syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Inhibitory B7-family molecules in the tumour microenvironment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

PD-1 and its ligands in tolerance and immunity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection-case report and review of the literature.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

International scoring system for evaluating prognosis in myelodysplastic syndromes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032802

Myelodysplastic syndromes

28 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.355

CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.355

Myelodysplastic Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.355

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.355

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.355

Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.355

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.355

Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.355

Impact of the hypomethylating agent 5-azacytidine on dendritic cells function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.355

Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome

21 January 2018

1 reference

12 December 2020

Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes

1 reference

12 December 2020

Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes

1 reference

12 December 2020

Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers

1 reference

12 December 2020

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes

1 reference

12 December 2020

Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2013.355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

PubMed publication ID

24270737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24270737%20AND%20SRC:MED&resulttype=core&format=json